Background Cardiac resynchronization therapy-defibrillators (CRT-D) are devices
established as treatment for symptomatic heart failure patients with an indication for CRT …

Aims The very long-term outcome of patients who survive the first few years after receiving
cardiac resynchronization therapy (CRT) has not been well described thus far. We aimed to …

Background The choice of cardiac resynchronization therapy device, with (CRT‐D) or
without (CRT‐P) a defibrillator, in patients with heart failure largely depends on the …

Background Contemporary data on national trends and outcomes in cardiac
resynchronization therapy with defibrillator (CRT-D) recipients following the 2012 updated …

Background—Candidates for cardiac resynchronization therapy (CRT) receive either a
biventricular pacemaker or a biventricular pacemaker with an implantable cardioverter …

Background The beneficial effects of a cardiac resynchronization defibrillator (CRT-D) in
patients with heart failure, low left ventricular ejection fraction (LVEF), and wide QRS have …

Aims Cardiac resynchronization therapy (CRT) with or without a defibrillator reduces
morbidity and mortality in selected patients with heart failure (HF) but response can be …

Background Cardiac resynchronisation therapy (CRT) reduces morbidity and mortality in
appropriately selected patients with heart failure and is strongly recommended for such …

Previous analyses have shown that there is lower mortality with cardiac resynchronization
therapy defibrillators (CRT-D) in patients with left bundle branch block (LBBB) but …

Aims The optimum timing of cardiac resynchronization therapy (CRT) implantation is
unknown. We explored long-term outcomes after CRT in relation to the time interval from a …